Alnylam Pharmaceuticals, Inc. (ALNY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
70.75-0.81 (-1.13%)
At close: 4:00 PM EDT
People also watch:
BMRNACORSGENACADALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open71.32
Prev Close71.56
Bid63.00 x 200
Ask79.80 x 200
Day's Range70.28 - 73.28
52wk Range49.96 - 110.75
1y Target EstN/A
Market Cap6.06B
P/E Ratio (ttm)-16.69
Beta1.90
Volume393,967
Avg Vol (3m)830,056
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Investopedia6 hours ago

    Top 10 Biotech Stocks for 2016 (ALXN, ALNY)

    The biotechnology sector has many growth opportunities for the remainder of 2016. Here are the top ten biotech stocks, with a summary and price target for each one.

  • Capital Cube6 days ago

    ETF’s with exposure to Alnylam Pharmaceuticals, Inc. : August 24, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Alnylam Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to ALNY-US. Comparing the performance and risk of Alnylam Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alnylam Pharmaceuticals, Inc. Cranks Out the Data
    Motley Fool18 days ago

    Alnylam Pharmaceuticals, Inc. Cranks Out the Data

    The development-stage biotech may not have any earnings, but it's producing plenty of data to keep investors interested.